The DOI matches its Crossref record; 34 of the 36 references it cites were found in a registry or an index.
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Open accessAbstract
Background & aims Norfloxacin is highly effective in preventing spontaneous bacterial peritonitis recurrence in cirrhosis, but its role in the primary prevention of this complication is uncertain.Methods Patients with cirrhosis and low protein ascitic levels (<15 g/L) with advanced liver failure (Child-Pugh score > or = 9 points with serum bilirubin level > or = 3 mg/dL) or impaired renal function (serum creatinine level > or = 1.2 mg/dL, blood urea nitrogen level > or = 25 mg/dL, or serum sodium level < or = 130 mEq/L) were included in a randomized controlled trial aimed at comparing norfloxacin (35 patients) vs placebo (33 patients) in the primary prophylaxis of spontaneous bacterial peritonitis. The main end points of the trial were 3-month and 1-year probability of survival. Secondary end points were 1-year probability of development of spontaneous bacterial peritonitis and hepatorenal syndrome.Results Norfloxacin administration reduced the 1-year probability of developing spontaneous bacterial peritonitis (7% vs 61%, P < .001) and hepatorenal syndrome (28% vs 41%, P = .02), and improved the 3-month (94% vs 62%, P = .003) and the 1-year (60% vs 48%, P = .05) probability of survival compared with placebo.Conclusions Primary prophylaxis with norfloxacin has a great impact in the clinical course of patients with advanced cirrhosis. It reduces the incidence of spontaneous bacterial peritonitis, delays the development of hepatorenal syndrome, and improves survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar to norfloxacin, rifaximin has been noted to increased survival in patients with advanced liver cirrhosis in several small-scale trials92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Moreover, several small-scale clinical studies have suggested that antibiotics such as norfloxacin and rifaximin increase survival in patients with liver cirrhosis92–95.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
In the citing paper
“Clinical trials in patients with advanced cirrhosis have shown that long-term use of orally administered norfloxacin is safe, produces a marked reduction of gram-negative bacteria in the faecal microbiota109, reduces the 1-year probability of developing spontaneous bacterial peritonitis and hepatorenal syndrome and improves 3-month survival92.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [92]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
Arroyo, V., Ginès, P., Gerbes, A. L., Dudley, F. J., Geñtilini, P., Laffi, G., Reynolds, T. B., Ring‐Larsen, H., & Schölmerich, J. (1996) · Hepatology · doi:10.1002/hep.510230122 · Cited by 1,694
Self-citationSort, P., Navasa, M., Arroyo, V., Aldeguer, X., Planas, R., Ruíz-del-Árbol, L., Castells, L., Vargas, V., Soriano, G., Guevara, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410603 · Cited by 1,636
Self-citationDiagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
Rimola, A., García–Tsao, G., Navasa, M., Piddock, L. J. V., Planas, R., Bernard‐Chabert, B., & Inadomi, J. M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80201-9 · Cited by 1,058
Self-citationFernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationIncidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
Ginés, À., Escorsell, À., Ginès, P., Saló, J., Jiménez, W., Inglada, L., Navasa, M., Clària, J., Rimola, A., Arroyo, V., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90031-7 · Cited by 874
Self-citationGinés, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., Forne, M., Miranda, M. L., Llach, J., Salmerón, J. M., et al. (1990) · Hepatology · doi:10.1002/hep.1840120416 · Cited by 627
Self-citationFollo, A., Llovet, J. M., Navasa, M., Planas, R., Forns, X., Francitorra, A., Rimola, A., Gassull, M. A., Arroyo, V., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200619 · Cited by 597
Self-citationCirculatory function and hepatorenal syndrome in cirrhosis†
Ruíz-del-Árbol, L., Monescillo, A., Arocena, C., Valer, P., Ginès, P., Moreira, V., Milicua, J. M., Jiménez, W., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20766 · Cited by 584
Self-citationRuíz-del-Árbol, L., Urmán, J., Fernández, J., González, M., Navasa, M., Monescillo, A., Albillos, A., Jiménez, W., & Arroyo, V. (2003) · Hepatology · doi:10.1053/jhep.2003.50447 · Cited by 496
Self-citationLlach, J., Ginès, P., Arroyo, V., Rimola, A., Titó, L., Badalamenti, S., Jiménez, W., Gaya, J., Rivera, F., & Rodés, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90441-6 · Cited by 457
Self-citation
Cited by
Sorted by citations
Items 201–300 of 709
Renal dysfunction in the perioperative liver transplant period
Biancofiore, G., & Davis, C. L. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328300a058 · Cited by 40
Spontaneous bacterial peritonitis: from pathophysiology to prevention
Bernardi, M. (2010) · Internal and Emergency Medicine · doi:10.1007/s11739-010-0446-x · Cited by 40
Treatment and management of ascites and hepatorenal syndrome: an update
Lenz, K., Buder, R., Kapun, L., & Voglmayr, M. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14564673 · Cited by 40
Acute kidney injury in acute on chronic liver failure
Maiwall, R., Sarin, S. K., & Moreau, R. (2015) · Hepatology International · doi:10.1007/s12072-015-9652-y · Cited by 40
Tergast, T. L., Laser, H., Gerbel, S., Manns, M. P., Cornberg, M., & Maasoumy, B. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0053-0 · Cited by 40
Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
Hayward, K. L., Valery, P. C., Martin, J. H., Karmakar, A., Patel, P. J., Horsfall, L. U., Tallis, C. J., Stuart, K. A., Wright, P. L., Smith, D. D., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i40.7321 · Cited by 39
Management of refractory cirrhotic ascites: challenges and solutions
Fukui, H., Kawaratani, H., Kaji, K., Takaya, H., & Yoshiji, H. (2018) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s136578 · Cited by 39
García–Tsao, G. (2012) · Goldman's Cecil Medicine · doi:10.1016/b978-1-4377-1604-7.00156-1 · Cited by 39
Current approaches to the management of patients with cirrhotic ascites
Garbuzenko, D. V., & Arefyev, N. O. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3738 · Cited by 39
Gordon, F. D. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.004 · Cited by 39
Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Madsen, B. S., Havelund, T., & Krag, A. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0044-1 · Cited by 38
Clostridium difficile infection in patients with liver disease: a review
Trifan, A. V., Stoica, O. C., Stanciu, C., Cojocariu, C., Sîngeap, A.-M., Gîrleanu, I., & Miftode, E. G. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2501-z · Cited by 38
Clinical and Pathophysiological Consequences of Alterations in the Microbiome in Cirrhosis
Macnaughtan, J., & Jalan, R. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.313 · Cited by 38
Management of Refractory Ascites
Singhal, S., Baikati, K., Jabbour, I. I., & Anand, S. (2010) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ff7a8b · Cited by 38
Hepatorenal Syndrome: A Critical Update
Wadei, H. M. (2012) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0032-1301735 · Cited by 38
Kamal, F., Khan, M. A., Khan, Z. H., Cholankeril, G. T., Hammad, T. A., Lee‐Smith, W., Ahmed, A., Waters, B., Howden, C. W., Nair, S., et al. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000940 · Cited by 37
Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?
Ribeiro, T. C. D. R. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s2688 · Cited by 35
Lontos, S., Shelton, E., Angus, P., Vaughan, R., Roberts, S. K., Gordon, A., & Gow, P. J. (2014) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12132 · Cited by 37
Huang, C., Lin, C., Sheen, I., Chen, W., Lin, T.-N., Ho, Y., & Chiu, C. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02377.x · Cited by 36
Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatment
Piotrowski, D., & Boroń‐Kaczmarska, A. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2016.11.009 · Cited by 36
Cullaro, G., Sharma, R., Trebicka, J., Cárdenas, A., & Verna, E. C. (2019) · Liver Transplantation · doi:10.1002/lt.25678 · Cited by 36
Cárdenas, A., & Ginès, P. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328329e154 · Cited by 36
Self-citationThe clinical challenges of acute on chronic liver failure
Graziadei, I. W. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02585.x · Cited by 36
Ascites and spontaneous bacterial peritonitis: An Asian perspective
Lee, J. M., Han, K., & Ahn, S. H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06020.x · Cited by 37
Hepatorenal syndrome: Current concepts and future perspectives
Jung, C., & Chang, J. W. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0024 · Cited by 35
Improving Survival in Decompensated Cirrhosis
Mukerji, A. N., Patel, V., & Jain, A. (2012) · International Journal of Hepatology · doi:10.1155/2012/318627 · Cited by 36
Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis
Salman, H., Shihab, E. M., Hasan, H. K., Abbas, A. H., Khorsheed, S. M., & Fakhri, S. A. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00152 · Cited by 34
Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options
Erly, B. K., Carey, W. W., Kapoor, B. S., McKinney, J. M., Tam, M., & Wang, W. (2015) · Seminars in Interventional Radiology · doi:10.1055/s-0035-1564794 · Cited by 34
Kasztelan‐Szczerbińska, B., Słomka, M., Celiński, K., Serwacki, M., Szczerbiński, M., & Cichoż‐Lach, H. (2011) · Advances in Medical Sciences · doi:10.2478/v10039-011-0010-6 · Cited by 33
Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival
Heidemann, J., Bartels, C., Berssenbrügge, C., Schmidt, H., & Meister, T. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/457613 · Cited by 33
Lee, P., Hsieh, Y.-C., Huo, T., Yang, U., Lin, C., Li, C., Huang, Y., Hou, M., Lin, H., & Lee, K. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000937 · Cited by 34
Toll‐like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patients
Guarner, C., Sánchez, E., Vidal, S., Román, E. M., Concepción, M., Poca, M., SÁNCHEZ, D., Juárez, C., Soriano, G., & Guarner, C. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04291.x · Cited by 33
Self-citationManagement of hepatorenal syndrome
McCormick, P. A., & Donnelly, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.012 · Cited by 33
García‐Martinez, I., Francés, R., Zapater, P., Giménez, P., Gómez‐Hurtado, I., Moratalla, A., Lozano‐Ruiz, B., Bellot, P., González-Navajas, J. M., & Such, J. M. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12667 · Cited by 32
Self-citationSoni, H., Kumar, P. M., Sharma, V., Bellam, B. L., Mishra, S., Mahendru, D., Mandavdhare, H. S., Medhi, B., Dutta, U., & Singh, V. (2020) · Hepatology International · doi:10.1007/s12072-020-10025-1 · Cited by 32
Gómez‐Hurtado, I., Zapater, P., Bellot, P., Pascual, S., Pérez‐Mateo, M., Such, J. M., & Francés, R. (2010) · Hepatology · doi:10.1002/hep.24102 · Cited by 32
Self-citationAl-Khafaji, A. H., Nadim, M. K., & Kellum, J. A. (2015) · CHEST Journal · doi:10.1378/chest.14-1925 · Cited by 32
Sheng, J. Q., Hu, P. J., Liu, X., Huang, T., & Chen, Y. (2020) · Journal of Medical Internet Research · doi:10.2196/18372 · Cited by 38
Acute Kidney Injury in Cirrhosis
Karvellas, C. J., Durand, F., & Nadim, M. K. (2015) · Critical Care Clinics · doi:10.1016/j.ccc.2015.06.009 · Cited by 31
Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients
Cadranel, J. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i3.104 · Cited by 31
Ascites and Hepatorenal Syndrome
Adebayo, D., Neong, S. F., & Wong, F. S.-H. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.06.002 · Cited by 31
Yang, Y., Hsieh, S.-L. E., Lee, P., Yeh, Y., Lee, K., Hsieh, Y., Wang, Y.-W., Lee, T.-Y., Huang, Y., Chan, C., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.049 · Cited by 33
Yim, H. J., Suh, S. J., Jung, Y. K., Yim, S. Y., Seo, Y. S., Lee, Y. R., Park, S. Y., Jang, J. Y., Kim, Y. S., Kim, H. S., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0168-7 · Cited by 30
Ascites and Spontaneous Bacterial Peritonitis
Runyon, B. A. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00091-3 · Cited by 30
Primary and secondary prophylaxis of spontaneous bacterial peritonitis: current state of the art
Facciorusso, A., Antonino, M., Orsitto, E., & Sacco, R. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1644167 · Cited by 29
Garbuzenko, D. V., & Arefyev, N. O. (2020) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12407 · Cited by 29
The Role of the Microbiome in Liver Cancer
Moreno‐Gonzalez, M., & Beraza, N. (2021) · Cancers · doi:10.3390/cancers13102330 · Cited by 29
Badal, B. D., Silvey, S. G., Dragilev, L., O’Leary, J. G., Morgan, T. R. M., Cheung, R. C., Patel, A., Rogal, S. S., Patton, H. M., Nobbe, A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000184 · Cited by 29
Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis
Garbuzenko, D. V. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i20.6117 · Cited by 30
Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study
Deleuran, T., Vilstrup, H., & Jepsen, P. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.107 · Cited by 28
Bajaj, J. S., Hassanein, T., Pyrsopoulos, N., Sanyal, A. J., Rahimi, R. S., Heimanson, Z., Israel, R. J., & Rockey, D. C. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.05.042 · Cited by 36
Spontaneous Bacterial Peritonitis in Decompensated Liver Cirrhosis—A Literature Review
Huang, C., Lee, C., & Chang, C. C. (2022) · Livers · doi:10.3390/livers2030018 · Cited by 30
Treatment for cirrhotic ascites
Kawaratani, H., Fukui, H., & Yoshiji, H. (2016) · Hepatology Research · doi:10.1111/hepr.12769 · Cited by 28
A deer in the headlights: BAMBI meets liver fibrosis
Friedman, S. L. (2007) · Nature Medicine · doi:10.1038/nm1107-1281 · Cited by 28
Bile Cast Nephropathy in Cirrhotic Patients
Foshat, M., Ruff, H., Fischer, W. G., Beach, R. E., Fowler, M. R., Ju, H., Aronson, J. F., & Afrouzian, M. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx030 · Cited by 27
Barbano, B., Sardo, L., Gigante, A., Gasperini, M. L., Liberatori, M., Giraldi, G. D. L., Lacanna, A., Amoroso, A., & Cianci, R. (2014) · Current Vascular Pharmacology · doi:10.2174/157016111201140327163930 · Cited by 27
Bajaj, J. S., Tandon, P., O’Leary, J. G., Wong, F. S.-H., Biggins, S. W., García–Tsao, G., Kamath, P. S., Maliakkal, B. J., Fallon, M. B., Lai, J. C., et al. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000044 · Cited by 27
Acute Kidney Injury in Liver Cirrhosis
Attieh, R. M., & Wadei, H. M. (2023) · Diagnostics · doi:10.3390/diagnostics13142361 · Cited by 26
Advances in the pharmacological management of bacterial peritonitis
Pörner, D., von Vietinghoff, S., Nattermann, J., Strassburg, C. P., & Lutz, P. L. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1915288 · Cited by 26
Testro, A., Gow, P. J., Angus, P., Wongseelashote, S., Skinner, N. A., Markovska, V. C., & Visvanathan, K. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.006 · Cited by 26
Ascites and spontaneous bacterial peritonitis: Recommendations from two United States centers
Al‐Osaimi, A. M. S., Sundaram, V., & Manne, V. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.141686 · Cited by 26
Prolonging Survival in Patients With Cirrhosis: Old Drugs With New Indications
Tsochatzis, E. A., Bosch, J., & Burroughs, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.031 · Cited by 25
Novel prevention strategies for bacterial infections in cirrhosis
Yan, K. G., & García–Tsao, G. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1145663 · Cited by 26
Barkin, J. S. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79056-4 · Cited by 26
Hepatorenal syndrome: Current concepts related to diagnosis and management.
Áz, D. M., Aa, D. M., & Méndez‐Sánchez, N. (2016) · PubMed · doi:10.5604/16652681.1202886 · Cited by 25
Management of Hepatorenal Syndrome: A Review
Tariq, R., & Singal, A. K. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00011 · Cited by 25
Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?
Piano, S. S., & Angeli, P. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.01.006 · Cited by 28
Facciorusso, A., Papagiouvanni, I., Cela, M., Buccino, V. R., & Sacco, R. (2019) · Liver International · doi:10.1111/liv.14109 · Cited by 25
A Pill a Day Can Improve Survival in Patients With Advanced Cirrhosis
Runyon, B. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.07.017 · Cited by 24
Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis
Solà, E., & Ginès, P. (2015) · Digestive Diseases · doi:10.1159/000375344 · Cited by 23
Self-citationSpontaneous Bacterial Peritonitis
Song, D. S. (2018) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2018.72.2.56 · Cited by 23
Leithead, J., Hayes, P. C., & Ferguson, J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12653 · Cited by 23
Giacalone, G., Matoori, S., Agostoni, V., Forster, V., Kabbaj, M., Eggenschwiler, S., Lussi, M., Gottardi, A. D., Zamboni, N., & Leroux, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.030 · Cited by 23
Management of Infectious Complications Associated with Acute-on-Chronic Liver Failure
Engelmann, C., & Berg, T. (2018) · Visceral Medicine · doi:10.1159/000491107 · Cited by 25
The Liver and Kidney in Critically Ill Patients
Slack, A. J., & Wendon, J. A. (2009) · Blood Purification · doi:10.1159/000227281 · Cited by 23
Thévenot, T., Elkrief, L., Bureau, C., Bardou‐Jacquet, E., Rosa, I., Nguyen-Khac, É., Oberti, F., Pitta, A., Mallet, M., Lebossé, F., et al. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.06.019 · Cited by 22
Park, J., Kim, B. W., Choi, H. J., Hong, S. H., Park, C. S., Choi, J. H., & Chae, M. S. (2020) · BMC Surgery · doi:10.1186/s12893-019-0658-6 · Cited by 22
Step by Step: Managing the Complications of Cirrhosis
Pérez, I., Bolte, F. J., Bigelow, W. A., Dickson, Z., & Shah, N. L. (2021) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s278032 · Cited by 22
Chaney, A. J. (2021) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s323778 · Cited by 22
Das, B. K. (2022) · Apmis · doi:10.1111/apm.13282 · Cited by 25
Difficult to treat spontaneous bacterial peritonitis
Shalimar, & Acharya, S. K. (2013) · Tropical Gastroenterology · doi:10.7869/tg.2012.84 · Cited by 22
Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies
Meltzer, J. S., & Brentjens, T. E. (2010) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32833724a8 · Cited by 22
Shi, K., Fan, Y., Li, Y., Lin, X.-F., Song, M. L., Li, L., Yu, X.-Y., Chen, Y., & Zheng, M. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1432-8 · Cited by 22
Zapater, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11493 · Cited by 22
Sood, S. S., Yu, L., Visvanathan, K., Angus, P., Gow, P. J., & Testro, A. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i35.1569 · Cited by 22
Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis
Dornas, W. C., & Lagente, V. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.026 · Cited by 22
Clostridium difficile Infection: Yet Another Predictor of Poor Outcome in Cirrhosis
García–Tsao, G., & Surawicz, C. M. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.604 · Cited by 22
Acute Kidney Injury Before and After Liver Transplant
DellaVolpe, J. D., & Al-Khafaji, A. H. (2018) · Journal of Intensive Care Medicine · doi:10.1177/0885066618790558 · Cited by 21
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status
Stojić, J., Kukla, M., & Grgurević, I. (2023) · Diagnostics · doi:10.3390/diagnostics13182960 · Cited by 21
Nieto, J. C., Sánchez, E., Romero, C., Román, E., Poca, M., Guarner, C., Juárez, C., Soriano, G., & Vidal, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ab0315-106r · Cited by 21
Self-citationCorradi, F., Brusasco, C., Fernández, J., Vilà, J., Ramírez‐Lázaro, M. J., Sevá‐Pereira, T., Fernández‐Varo, G., Mosbah, I. B., Acevedo, J., Silva, A., et al. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.10.014 · Cited by 21
Self-citationGómez‐Hurtado, I., Moratalla, A., Moya-Pérez, Á., Peiró, G., Zapater, P., González-Navajas, J. M., Giménez, P., Such, J. M., Sanz, Y., & Francés, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.031 · Cited by 21
Self-citationLutz, P. L., Goeser, F., Kaczmarek, D. J., Schlabe, S., Nischalke, H. D., Nattermann, J., Hoerauf, A. M., Strassburg, C. P., & Spengler, U. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4637-4 · Cited by 21
Bacterial Infection in Patients with Cirrhosis: Don’t Get Bugged to Death
Cannon, M. D., Martin, P. B., & Carrion, A. F. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05943-6 · Cited by 21
Meighani, A., Alimirah, M., Ramesh, M. S., & Salgia, R. J. (2020) · International Journal of Hepatology · doi:10.1155/2020/1874570 · Cited by 21
Sepsis in Patients With Cirrhosis Awaiting Liver Transplantation: New Trends and Management
Martín‐Mateos, R., & Albillos, A. (2019) · Liver Transplantation · doi:10.1002/lt.25621 · Cited by 21
Pimentel, R., Gregório, C., & Figueiredo, P. (2021) · Acta gastro-enterologica belgica · doi:10.51821/84.2.333 · Cited by 20
A Review of Hepatorenal Syndrome
Subedi, A., Kumar, V. C. S., Subedi, A. S., & Sapkota, B. H. (2021) · Cureus · doi:10.7759/cureus.16084 · Cited by 20
Risk factors of cellulitis in cirrhosis and antibiotic prophylaxis in preventing recurrence.
Hamza, R. E., Villyoth, M. P., Peter, G., Joseph, D., Govindaraju, C., Tank, D. C., Sreesh, S., Narayanan, P., & Vinayakumar, K. R. (2014) · Europe PMC (PubMed Central) · Cited by 20
Spontaneous bacterial peritonitis
Barreales, M., & Fernández, I. (2011) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082011000500006 · Cited by 20
Metadata
- Authors
- Fernández, J., Navasa, M., Planas, R., Montoliu, S., Monfort, D., Soriano, G., Vila, C., Pardo, A., Quintero, E., Vargas, V., Such, J., Ginès, P., & Arroyo, V.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Hospital Universitari Germans Trias i Pujol (ES)
- Hospital de Sant Pau (ES)
- Hospital Del Mar (ES)
- Hospital Universitario de Canarias (ES)
- Corresponding author
- Navasa, Miquel
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 133
- Issue
- 3
- Pages
- 818-824
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2012746560
- Cited by
- 709
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 23 · 2023: 37 · 2022: 28 · 2021: 43 · 2020: 39 · 2019: 42 · 2018: 42 · 2017: 37 · 2016: 34 · 2015: 55 · 2014: 48 · 2013: 31 · 2012: 46
- FWCI
- 30.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- spontaneous bacterial peritonitis, primary prophylaxis, norfloxacin, hepatorenal syndrome, liver cirrhosis, survival, renal dysfunction, antibiotic prophylaxis
- MeSH terms
- Aged, Anti-Infective Agents, Double-Blind Method, Female, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Male, Middle Aged, Norfloxacin, Peritonitis, Risk Factors, Survival Analysis, Antibiotic Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
